ECM
AMAG

Everence Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Everence Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,250
Closed -$162K – 753
2020
Q3 		$162K Buy
+17,250
New +$164K 0.02% 617

Everence Capital Management's AMAG Position: Q4 2020 in Review

Everence Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 17,250 shares — an estimated $162K sold.

Everence Capital Management first reported a position in AMAG in Q3 2020 and held it in 1 quarter. The position peaked at $162K in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Everence Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Everence Capital Management sold 17,250 AMAG Pharmaceuticals shares in Q4 2020, an estimated $162K.
  • Everence Capital Management first reported a position in AMAG Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Everence Capital Management's AMAG Pharmaceuticals position peaked at $162K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Everence Capital Management's 13F filing for Q4 2020, filed 11 Jan 2021.